Research

RSS feed for this section

A GREAT Day for Celiac Disease

great-logo-copy1

Celiac Disease Foundation is proud to have been a funder and to participate on the Steering Committee for the FDA Gastroenterology Regulatory Endpoints and Advancement of Therapeutics (GREAT3) workshop. Conceived by Dr. Sonia Kupfer of the University of Chicago and CDF Medical Advisory Board member Dr. Daniel Leffler of Beth Israel Deaconess Medical Center, GREAT3 […]

ICDS 2015 Highlights

ICDS Logo

The 16th International Celiac Disease Symposium (ICDS 2015) was held June 21-23, 2015, in Prague, Czech Republic. The largest international gathering of physicians, dietitians, researchers, and academics in the field of celiac disease, ICDS 2015 included scientific, clinical and patient forums focusing on the latest developments. REPRESENTING YOU To ensure that your voice and the […]

Probiotics, Your Friend or Foe?

CDF_Research_4x4in

Probiotics are live microorganisms that, when taken as a supplement, can help establish a healthy balance of bacteria in the gut. For many, the word bacteria often carries a negative connotation; however, bacteria play a crucial role in maintaining normal GI function and protecting the body from infection. Although there is no evidence-based research to […]

Promising Results for Celiac Disease Pipeline Drug

CDF_Research_4x4in

Celiac disease is a genetic autoimmune condition triggered by gluten that causes the body’s immune system to attack itself, damaging the small intestine. A wide range of symptoms can occur in different individuals, including but not limited to: unexplained iron-deficiency anemia, fatigue, bone or joint pain, arthritis, seizures or migraines, abdominal bloating and pain, and […]

Neuropathy Linked to Celiac Disease

CDF_Research_4x4in

A member of CDF’s Medical Advisory Board, Peter Green, MD, recently studied the relationship between celiac disease (CD) and neuropathy, along with the expert knowledge of doctors Thawani, Brannagan, Lebwohl, and Ludviggson. Neuropathy is a condition that weakens nerve cells and inhibits normal nerve function. Our nerves are used for communicating with the brain and […]

CDF Attends 2015 Digestive Disease Week

CDF_Research_4x4in-150x150

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. Held on May 16-19 in Washington D.C., the meeting showcased new breakthroughs in celiac disease and gluten sensitivity research. Celiac Disease Foundation (CDF) Chief Executive Officer, Marilyn G. Geller, attended to […]

Gluten-Free Diet and Asymptomatic Celiac Disease

CDF_Research_4x4in

In the United States, an estimated three million Americans suffer from celiac disease. Due to lack of information about celiac disease manifestation, roughly 83% of Americans who experience symptoms go undiagnosed, and as a result, are not aware of the damage to their intestinal lining. There are also those who have the disease but show […]

CDF Presents Patient-Focused Celiac Drug Development Survey Data to FDA

CDF_Research_404x404

On May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ […]